An assessment of the potential exposure resulting from the use of PNR 1427 flea collars containing imidacloprid as an active ingredient was calculated for post application contact with treated cats, small dogs, and large dogs. The small flea collars weigh 12.5 grams and contain 1.25 grams imidacloprid and are intended for use on cats or small dogs up to 8 kg in weight. The large flea collar is intended for dogs weighing over 8 kg and weighs 45.0 grams, with 4.5 grams of imidacloprid.
Appendix I: Neuropathology and Morphometry Procedures for the guideline DNT study with Imidacloprid

Neuropathology and Morphometry -PND 11
Brains were divided into eight coronal blocks (including forebrain, cerebrum, midbrain, cerebellum, pons and medulla oblongata) for microscopic examination (Fig. 1) . Each block was processed according to standard procedures for paraffin embedding and sectioned at 5 µm, with slides prepared with hematoxylin and eosin (H&E), luxol fast blue/cresyl violet and Sevier-Munger stains.
Seven linear measurements were taken from brain sections (levels 4, 5 and 7), as follows: (1) Frontal cortex thickness (forebrain); the dorsal portion of the cerebral cortex within the coronal section passing through the region of the optic chiasm; (2) Parietal cortex thickness (forebrain); the dorsolateral portion of the cerebral cortex within the coronal section taken through the optic chiasm; (3) Caudate putamen horizontal width (forebrain; maximum cross-sectional width) -performed on the coronal section, taken at the level of the optic chiasm; (4) Corpus callosum thickness (forebrain) -at the mid-point, from the section taken at the level of the optic chiasm; (5) Hippocampal gyrus thickness (midbrain) -the full width of the hippocampal gyrus from the ventral tail of the dentate gyrus to the overlying subcortical white matter; (6) Cerebellum height (cerebellum/pons) -from the roof of the fourth ventricle to the dorsal surface; and (7) External germinal layer (cerebellum) thickness (cerebellum/pons; PND 11 only) -due to considerable regional differences in thickness, multiple areas were measured over the dorsum of the cerebellum.
Neuropathology and Morphometry -PND 75
The brain and spinal cord, both eyes (with optic nerves) and selected (bilateral) peripheral nerves (sciatic, tibial, and sural), the gasserian ganglion, gastrocnemius muscle, and both forelimbs were collected from each animal and post-fixed in 10% buffered formalin. The fixed brain was weighed upon removal from the skull, before placement into formalin.
Vernier calipers were used to obtain two linear measurements of the brain, as described for the PND 11 pups. The following tissues from control and high-dose perfused animals, and any gross lesions collected at necropsy, were routinely processed for microscopic examination:
• 8 coronal sections of the brain, including forebrain, center of cerebrum, midbrain, cerebellum, pons, and medulla oblongata; • 4 sections from 3 levels of the spinal cord (cervical, thoracic, and lumbar) and the cauda equina were embedded in paraffin and stained with H&E, luxol fast blue/cresyl violet, and Sevier-Munger stains; • Eyes, optic nerves, and gastrocnemius muscle were embedded in paraffin and stained with H&E;
• Dorsal root ganglia (including dorsal and ventral root fibers) from the cervical and lumbar swellings, gasserian ganglia, and peripheral nerve tissues (sciatic, tibial, and sural) were embedded in glycol methacrylate resin (GMA), sectioned at 2-3 µm, and stained with a modified Lee's stain. Microscopic evaluation and measurements of brain tissue were performed as described for the PND 11 animals, with modifications appropriate for the adult.
The CHECKED (X) tissues will be evaluated for adult offspring. 
CENTRAL NERVOUS SYSTEM PERIPHERAL NERVOUS SYSTEM
INTRODUCTION
PNR 1427T and PNR 1427G are antiparasitic collars for flea and tick control for cats and dogs, respectively. Both collars contain 10% imidacloprid as an active ingredient. The collars will be used for an eight month period and therefore would be used once per year in many regions of the United States and no more than twice per year in the warmer regions of the country. The purpose of this exposure and risk assessment is to support the registration application for PNR 1427T and PNR 1427G.
PNR 1427 Release Kinetics
The flea collar contains a patented Bayer polymer matrix system that ensures the active ingredients are slowly and continuously released in low concentrations from the collar towards the animal. This minimizes peak concentrations and ensures that acaricidal / insecticidal concentrations are present in the dog or cat's haircoat during the entire eight month efficacy period. The active substances spread from the site of direct contact over the entire skin surface. Bayer conducted several studies to quantify the release rate of imidacloprid from the collar and also to measure residues on the animal's fur over time.
Toxicology (imidacloprid)
HED selected a NOEL of 10 mg/kg/day from the rat developmental toxicity study as the most appropriate endpoint for short-term oral, dermal, and inhalation exposure risk assessments. A NOEL of 9.3 mg/kg/day from the rat subchronic neurotoxicity toxicity study was selected as the most appropriate endpoint for intermediate-term oral, dermal, and inhalation exposure risk assessments. For the purpose of this assessment the intermediate-term NOEL of 9.3 mg/kg/day is used to address both short-term and intermediate-term exposures. Based on the results of the dermal absorption study a dermal absorption adjustment of 4.2% is used for the dermal exposure risk assessment.
POST-APPLICATION EXPOSURE AND RISK
Post-application exposure to imidacloprid contained in the flea collars is estimated based on the guidance provided in the "Current Guidance for Residential Exposure Risk Assessment for Pet Insecticide Treatments" of 14 January 2009. Post application exposure occurs from pet owner contact with the dog or cat wearing the flea collar. The guidance for pet flea collar assessments assumes that the daily dose on the day of application is based on 20% of the maximum application rate being available on the pet's body and transferred to adults and children as a dislodgeable residue.
As previously stated, the cat/small dog flea collar contains 1.25 grams of imidacloprid and the large dog flea collar contains 4.50 grams of imidacloprid. Based on the kinetic data, the daily release rates are 8.35 mg/day and 22.7 mg/day of imidacloprid from the small and large collars, respectively.
The small flea collar will be used to assess exposure to a 9 lb cat and the large flea collar will be used to assess exposure to a 30 lb dog. The HED defaults for the surface area of the cat and dog are 2737 cm 2 for the cat and 5986 cm 2 for the dog. The Agency uses the single hug method to assess post application dermal exposure with a 5625 cm 2 surface area for 70 kg adults and 1875 cm 2 for a 15 kg 3 year old child. Post Application Dermal Risk to Dogs Adult: 9.3 mg/kg/day ÷ 2.6 x 10 -3 mg/kg/day = 3,577 Child: 9.3 mg/kg/day ÷ 4.0 x 10 -3 mg/kg/day = 2,325
Post application incidental oral exposure is only calculated for the three year old child. An equilibrium approach is taken by HED and assumes that 20% of the available residues are available for transfer to the hands of the child. The surface area of the hands that provide oral contact is 20 cm 2 and that the saliva removes 50% of the residue that is transferred to the hands. The oral NOAEL of 9.3 mg/kg/day is used to calculate the MOEs for imidacloprid. The oral incidental exposure to the child is calculated as follows: Post Application Exposure and Risk Summary Adult post application exposure resulting from contact with the treated animal is by the dermal route of exposure resulting from the transfer of imidacloprid residues from the animal's fur to the adult's skin. The imidacloprid exposures were calculated to be 2.1 x 10 -3 mg/kg/day for animals wearing the small collar and 2.6 x 10 -3 mg/kg/day for animals wearing the large collar. The resultant MOEs were 4,429 and 3,577 for the small and large collars, respectively.
The total post application exposure and risk to small children contacting pets wearing the flea collars results from both the dermal contact and the incidental ingestion of imidacloprid residues from the hands. For children contacting pets wearing the small collars, the aggregate post application exposure to imidacloprid is 3.61 x 10 -3 mg/kg/day and 4.51 x 10 -3 mg/kg/day with the large collar. The dermal and oral NOAEL for imidacloprid is 9.3 mg/kg/day and the aggregate MOEs for the small child are 2,576 with the small collar and 2,062 with the large collars.
CONCLUSIONS
An assessment of the potential exposure resulting from the use of PNR 1427 flea collars containing imidacloprid as an active ingredient was calculated for post application contact with treated cats, small dogs, and large dogs. The small flea collars weigh 12.5 grams and contain 1.25 grams imidacloprid and are intended for use on cats or small dogs up to 8 kg in weight. The large flea collar is intended for dogs weighing over 8 kg and weighs 45.0 grams and contains 4.5 grams of imidacloprid.
The daily application rate of imidacloprid from the collars to the pets was determined based on release rate kinetic studies. Approximately 40% of the imidacloprid is released over an eight month period at a rate that slightly decreases over the period. During the first month of use when the release rate is slightly higher the daily rate of release of imidacloprid from the small collar is 8.35 mg/day and from the large collar it is 22.7 mg/day. Fur kinetic data supported the release rate kinetics.
The revised HED guidelines for pet exposure and risk assessments were used with the release rate data to estimate the exposure and risks to adults applying the collars and to both adults and small children contacting pets wearing the collars. MOEs for adult post application contact with the treated pets ranged from 2,200 to 4,400. The aggregate oral and dermal MOEs for small children ranged from 1,300 to 2,600. Crofton et al. (1993) MAM control (n=8) 42 Goldey et al. (1994) Methylmercury control (n=8) 58 Goldey et al. (1994) Methanol control (n=6) 58 Stanton et al. (1995) Propylthiouracil control (n=6) 27 58 Goldey et al. (1995a) Aroclor 1254 (n=8) 27 55 Goldey et al. (1995b) Aroclor 1254 & thyroxine replacement (n=8) 27 27 Goldey and Crofton (1998) Iodine levels (assume n=12 for males based on figure legend for cognitive test) 60 Gilbert et al. (2013) Average 30 51
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Note: DNT -developmental neurotoxicity IDPN -3,3'-iminodiproprionitrile (a within-litter study design) MAM -methylazoxymethanol PND -post-natal day a The startle reflex with blank prepulse in the reflex modification design is comparable to the startle reflex in the habituation design. The CVs were estimated from the figures which reported total session peak amplitude and the SEM. Sample size (n) was used to calculate SD from SEM [SD = SEM * SQRT(n)]. CV=SD x 100/mean Suppl. 
